Anti-™9SF3 monoclonal antibody

Pre-made anti-™9SF3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™9SF3/™9SF3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1929-Ab-1/ GM-Tg-hg-IP1929-Ab-2Anti-Human ™9SF3 monoclonal antibodyHuman
GM-Tg-rg-IP1929-Ab-1/ GM-Tg-rg-IP1929-Ab-2Anti-Rat ™9SF3 monoclonal antibodyRat
GM-Tg-mg-IP1929-Ab-1/ GM-Tg-mg-IP1929-Ab-2Anti-Mouse ™9SF3 monoclonal antibodyMouse
GM-Tg-cynog-IP1929-Ab-1/ GM-Tg-cynog-IP1929-Ab-2Anti-Cynomolgus/ Rhesus macaque ™9SF3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1929-Ab-1/ GM-Tg-felg-IP1929-Ab-2Anti-Feline ™9SF3 monoclonal antibodyFeline
GM-Tg-cang-IP1929-Ab-1/ GM-Tg-cang-IP1929-Ab-2Anti-Canine ™9SF3 monoclonal antibodyCanine
GM-Tg-bovg-IP1929-Ab-1/ GM-Tg-bovg-IP1929-Ab-2Anti-Bovine ™9SF3 monoclonal antibodyBovine
GM-Tg-equg-IP1929-Ab-1/ GM-Tg-equg-IP1929-Ab-2Anti-Equine ™9SF3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1929-Ab-1/ GM-Tg-hg-IP1929-Ab-2; GM-Tg-rg-IP1929-Ab-1/ GM-Tg-rg-IP1929-Ab-2;
GM-Tg-mg-IP1929-Ab-1/ GM-Tg-mg-IP1929-Ab-2; GM-Tg-cynog-IP1929-Ab-1/ GM-Tg-cynog-IP1929-Ab-2;
GM-Tg-felg-IP1929-Ab-1/ GM-Tg-felg-IP1929-Ab-2; GM-Tg-cang-IP1929-Ab-1/ GM-Tg-cang-IP1929-Ab-2;
GM-Tg-bovg-IP1929-Ab-1/ GM-Tg-bovg-IP1929-Ab-2; GM-Tg-equg-IP1929-Ab-1/ GM-Tg-equg-IP1929-Ab-2
Products NameAnti-™9SF3 monoclonal antibody
Formatmab
Target Name™9SF3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™9SF3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1929-Ag-1Recombinant multi-species ™9S3/ ™9SF3/ EP70-P-iso protein
    ORF Viral VectorpGMLPm004053mouse Tm9sf3 Lentivirus plasmid
    ORF Viral VectorvGMLPm004053mouse Tm9sf3 Lentivirus particle


    Target information

    Target IDGM-IP1929
    Target Name™9SF3
    Gene ID56889,107358,309475,704905,612786,101097763,614147,100070803
    Gene Symbol and Synonyms1810073M23Rik,2810031D16Rik,EP70-P-iso,mKIAA4036,RGD1564625,SMBP,™9SF3
    Uniprot AccessionQ9HD45
    Uniprot Entry Name™9S3_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000077147
    Target ClassificationN/A

    The target: ™9SF3, gene name: ™9SF3, also named as EP70-P-iso, SMBP. Predicted to be involved in protein localization to membrane. Predicted to be located in exocytic vesicle. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.